Firefly Neuroscience, Inc. (AIFF)
NASDAQ: AIFF · Real-Time Price · USD
1.070
+0.010 (0.94%)
Sep 10, 2026, 4:00 PM EDT - Market closed
Firefly Neuroscience Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 9.23 | 2.75 | 1.81 | 2.14 | 0.06 | 0.65 |
Cash & Short-Term Investments | 9.23 | 2.75 | 1.81 | 2.14 | 0.06 | 0.65 |
Cash Growth | 55.90% | 51.77% | -15.54% | 3594.83% | -91.12% | - |
Accounts Receivable | 0.13 | 0.19 | 0.12 | 0.08 | - | - |
Other Receivables | 0.06 | - | - | - | 0.02 | 0.04 |
Receivables | 0.19 | 0.19 | 0.12 | 0.08 | 0.02 | 0.04 |
Inventory | 0.04 | 0.11 | - | - | - | - |
Prepaid Expenses | 0.37 | 0.2 | 0.28 | 0.03 | 0.01 | 0.01 |
Other Current Assets | 0.39 | 0.78 | 0.42 | - | - | - |
Total Current Assets | 10.23 | 4.03 | 2.63 | 2.26 | 0.08 | 0.7 |
Property, Plant & Equipment | 0.23 | 0.15 | 0.14 | - | - | 0.19 |
Goodwill | 5.18 | 5.18 | - | - | - | - |
Other Intangible Assets | 0.18 | 0.21 | 0.18 | 0.39 | - | 0 |
Long-Term Deferred Charges | 0.61 | 0.65 | 0.97 | - | - | - |
Other Long-Term Assets | 0.35 | 0.27 | 0.68 | - | 0.05 | 0.06 |
Total Assets | 16.77 | 10.48 | 4.6 | 2.64 | 0.14 | 0.95 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.88 | 1.35 | 1.82 | 0.63 | 0.42 | 0.5 |
Accrued Expenses | 0.52 | 0.26 | 1.63 | 1.9 | 0.86 | 0.75 |
Short-Term Debt | - | - | 0.69 | - | 0.18 | 2.26 |
Current Portion of Leases | - | 0.51 | - | - | - | - |
Current Unearned Revenue | 0.22 | 0.23 | 0.01 | - | 0.91 | 0.46 |
Other Current Liabilities | 0.48 | 0.48 | 0.83 | - | - | - |
Total Current Liabilities | 2.1 | 2.82 | 4.98 | 2.53 | 2.36 | 3.97 |
Long-Term Unearned Revenue | 0.01 | 0.02 | - | - | - | - |
Total Liabilities | 2.11 | 2.84 | 4.98 | 2.53 | 2.36 | 3.97 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | - | - | - | - |
Additional Paid-In Capital | 130.22 | 119.25 | 86.71 | 76.73 | 71.8 | 61.89 |
Retained Earnings | -115.56 | -111.62 | -87.08 | -76.62 | -74.02 | -67.33 |
Total Common Equity | 14.66 | 7.64 | -0.38 | 0.11 | -2.23 | -5.44 |
Shareholders' Equity | 14.66 | 7.64 | -0.38 | 0.11 | -2.23 | -3.01 |
Total Liabilities & Equity | 16.77 | 10.48 | 4.6 | 2.64 | 0.14 | 0.95 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | - | 0.51 | 0.69 | - | 0.18 | 2.26 |
Net Cash (Debt) | 9.23 | 2.24 | 1.12 | 2.14 | -0.12 | -1.6 |
Net Cash Growth | 55.90% | 100.90% | -47.92% | - | - | - |
Net Cash Per Share | 0.59 | 0.18 | 0.17 | 0.66 | -0.09 | - |
Filing Date Shares Outstanding | 15.69 | 14.79 | 11.62 | 35.37 | 2.55 | - |
Total Common Shares Outstanding | 15.68 | 13.96 | 8.12 | 35.37 | 2.55 | - |
Working Capital | 8.13 | 1.21 | -2.35 | -0.28 | -2.28 | -3.26 |
Book Value Per Share | 0.93 | 0.55 | -0.05 | 0.00 | -0.87 | - |
Tangible Book Value | 9.31 | 2.25 | -0.56 | -0.28 | -2.23 | -5.44 |
Tangible Book Value Per Share | 0.59 | 0.16 | -0.07 | -0.01 | -0.87 | - |
Machinery | 0.19 | 0.18 | 0.15 | - | - | 3.98 |